Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2010

01.12.2010 | Original Research

Statin Utilization in Nursing Home Patients after Cardiac Hospitalization

verfasst von: Seema Parikh, MBBS, MPH, William H. Shrank, MD, MSHS, Helen Mogun, MSc, Niteesh K. Choudhry, MD, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Coronary artery disease (CAD) is highly prevalent in nursing home residents and is associated with a substantial clinical and economic burden. Statins reduce mortality and hospitalization rates in older patients with CAD.

OBJECTIVES

To assess rates and predictors of statin use among high-risk patients with symptomatic coronary artery disease (CAD) admitted to nursing homes after acute cardiac hospitalization.

DESIGN

Cohort study.

PARTICIPANTS

Medicare beneficiaries enrolled in either a state-run drug assistance program or Medicaid in nursing homes in New Jersey from 1994 through 2005.

MEASUREMENTS

Statin utilization within 60 days of nursing home admission was determined for patients recently hospitalized with symptomatic CAD in whom statins are indicated consisting of those with: acute coronary syndrome (ACS) without revascularization, ACS with revascularization and congestive heart failure (CHF) with revascularization. Predictors of statin use were evaluated with multivariate logistic regression models.

RESULTS

While statin use over the 11-year period increased from 1.2% to 31.8%, overall utilization was very low. Predictors of greater statin use included prior cardiac hospitalization [odds ratio (OR) 1.32, 95% confidence interval (95% CI) 1.13 to 1.57], prior statin use (OR 6.92, 95% CI 5.86 to 8.82) and receipt of a concurrent cardiac medication (range of odds ratios, 2.36–3.40). Older patients admitted for ACS with or without revascularization were less likely to receive a statin. Patients who had received anti-platelets or angiotensin-modifying agents prior to their hospitalization were less likely to receive statins after discharge. Renal disease, prior stroke, diabetes, hypertension and hyperlipidemia did not influence statin utilization. Predictors of treatment did not change when the cohort was dichotomized according to length of stay.

CONCLUSIONS

Patients are infrequently treated with statins when discharged to nursing homes following hospitalization for a symptomatic cardiovascular event. Barriers to statin treatment in this setting require closer examination.
Literatur
1.
2.
Zurück zum Zitat Aronow WS. Clinical causes of death of 2,372 older persons in a nursing home during 15-year follow-up. J Am Med Dir Assoc. 2000;1:95–6.PubMed Aronow WS. Clinical causes of death of 2,372 older persons in a nursing home during 15-year follow-up. J Am Med Dir Assoc. 2000;1:95–6.PubMed
3.
Zurück zum Zitat Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1,160 older men and 2,464 older women in a long-term health care facility. J Gerontol A Biol Sci Med Sci. 2002;57:M45–6.PubMed Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1,160 older men and 2,464 older women in a long-term health care facility. J Gerontol A Biol Sci Med Sci. 2002;57:M45–6.PubMed
4.
Zurück zum Zitat Segev A, Strauss BH, Tan M, et al. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries). Am J Cardiol. 2006;98:470–3.CrossRefPubMed Segev A, Strauss BH, Tan M, et al. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries). Am J Cardiol. 2006;98:470–3.CrossRefPubMed
5.
Zurück zum Zitat Grady KL. Quality of life in patients with chronic heart failure. Crit Care Nurs Clin North Am. 1993;5:661–70.PubMed Grady KL. Quality of life in patients with chronic heart failure. Crit Care Nurs Clin North Am. 1993;5:661–70.PubMed
6.
Zurück zum Zitat Mayou R, Blackwood R, Bryant B, Garnham J. Cardiac failure: symptoms and functional status. J Psychosom Res. 1991;35:399–407.CrossRefPubMed Mayou R, Blackwood R, Bryant B, Garnham J. Cardiac failure: symptoms and functional status. J Psychosom Res. 1991;35:399–407.CrossRefPubMed
7.
Zurück zum Zitat Javitz HS, Ward MM, Watson JB, Jaana M. Cost of illness of chronic angina. Am J Manag Care. 2004;10:S358–69.PubMed Javitz HS, Ward MM, Watson JB, Jaana M. Cost of illness of chronic angina. Am J Manag Care. 2004;10:S358–69.PubMed
8.
Zurück zum Zitat Lye M, Valacio R, Reckless JP, et al. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin. Coron Artery Dis. 1998;9:583–90.CrossRefPubMed Lye M, Valacio R, Reckless JP, et al. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin. Coron Artery Dis. 1998;9:583–90.CrossRefPubMed
9.
Zurück zum Zitat Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11:1–160. iii-iv. Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007;11:1–160. iii-iv.
10.
Zurück zum Zitat DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994–2001: a case of agism but not of sexism? Heart. 2003;89:417–21.CrossRefPubMed DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994–2001: a case of agism but not of sexism? Heart. 2003;89:417–21.CrossRefPubMed
11.
Zurück zum Zitat Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–72.CrossRefPubMed Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–72.CrossRefPubMed
12.
Zurück zum Zitat Eaton CB, Lapane KL, Murphy JB, Hume AL. Effect of statin (HMG-Co-A-reductase inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc. 2002;50:1389–95.CrossRefPubMed Eaton CB, Lapane KL, Murphy JB, Hume AL. Effect of statin (HMG-Co-A-reductase inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc. 2002;50:1389–95.CrossRefPubMed
13.
Zurück zum Zitat U.S. Dept. of Health and Human Services, National Center for Health Statistics. National Nursing Home Survey, 1999. U.S. Dept. of Health and Human Services, National Center for Health Statistics. National Nursing Home Survey, 1999.
14.
Zurück zum Zitat Williams MA, Fleg JL, Ades PA, et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2002;105:1735–43.CrossRefPubMed Williams MA, Fleg JL, Ades PA, et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2002;105:1735–43.CrossRefPubMed
15.
Zurück zum Zitat Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134:932–8.CrossRefPubMed Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134:932–8.CrossRefPubMed
16.
Zurück zum Zitat Choudhry NK, Levin R, Winkelmayer WC. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007;93:945–51.CrossRefPubMed Choudhry NK, Levin R, Winkelmayer WC. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007;93:945–51.CrossRefPubMed
17.
Zurück zum Zitat Shah SJ, Waters DD, Barter P, et al. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol. 2008;51:1938–43.CrossRefPubMed Shah SJ, Waters DD, Barter P, et al. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol. 2008;51:1938–43.CrossRefPubMed
18.
Zurück zum Zitat Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons ≥65 years of age. Am J Cardiol. 2007;100:1061–7.CrossRefPubMed Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons ≥65 years of age. Am J Cardiol. 2007;100:1061–7.CrossRefPubMed
19.
Zurück zum Zitat Ye X, Gross CR, Schommer J, Cline R, Xuan J, St Peter WL. Initiation of statins after hospitalization for coronary heart disease. J Manag Care Pharm. 2007;13:385–96.PubMed Ye X, Gross CR, Schommer J, Cline R, Xuan J, St Peter WL. Initiation of statins after hospitalization for coronary heart disease. J Manag Care Pharm. 2007;13:385–96.PubMed
20.
Zurück zum Zitat Joseph J, Koka M, Aronow WS. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. J Am Med Dir Assoc. 2008;9:124–7.CrossRefPubMed Joseph J, Koka M, Aronow WS. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. J Am Med Dir Assoc. 2008;9:124–7.CrossRefPubMed
21.
Zurück zum Zitat Ghosh S, Ziesmer V, Aronow WS. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home. J Gerontol A Biol Sci Med Sci. 2002;57:M398–400.PubMed Ghosh S, Ziesmer V, Aronow WS. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home. J Gerontol A Biol Sci Med Sci. 2002;57:M398–400.PubMed
22.
Zurück zum Zitat Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD. Underutilization of antithrombotic therapy in atrial fibrillation. J R Soc Med. 2000;93:138–40.PubMed Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD. Underutilization of antithrombotic therapy in atrial fibrillation. J R Soc Med. 2000;93:138–40.PubMed
23.
Zurück zum Zitat Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc. 1998;46:1423–4.PubMed Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc. 1998;46:1423–4.PubMed
24.
Zurück zum Zitat Mendelson G, Aronow WS. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1998;46:751–2.PubMed Mendelson G, Aronow WS. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1998;46:751–2.PubMed
25.
Zurück zum Zitat Levy CR, Radcliff TA, Williams ET, Hutt E. Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc. 2009;10:56–61.CrossRefPubMed Levy CR, Radcliff TA, Williams ET, Hutt E. Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc. 2009;10:56–61.CrossRefPubMed
26.
Zurück zum Zitat Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.CrossRefPubMed Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.CrossRefPubMed
27.
Zurück zum Zitat Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc. 2007;55:420–5.CrossRefPubMed Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc. 2007;55:420–5.CrossRefPubMed
28.
Zurück zum Zitat Aronow WS. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl. Am J Cardiol 1998; 82: 668-9, A6, A8. Aronow WS. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl. Am J Cardiol 1998; 82: 668-9, A6, A8.
Metadaten
Titel
Statin Utilization in Nursing Home Patients after Cardiac Hospitalization
verfasst von
Seema Parikh, MBBS, MPH
William H. Shrank, MD, MSHS
Helen Mogun, MSc
Niteesh K. Choudhry, MD, PhD
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2010
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1473-z

Weitere Artikel der Ausgabe 12/2010

Journal of General Internal Medicine 12/2010 Zur Ausgabe

Healing Arts: Materia Medica

Becoming a Father

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.